Abstract

BackgroundAtrial fibrillation (AF) is a particularly prevalent and challenging to manage disease in the elderly. This study aims to evaluate the adequacy of ESC guidelines for the management of AF in a clinical setting with an aged population. MethodsRetrospective study of 212 hospitalizations with a diagnosis of AF. Patients admitted to the unit from January to June of 2012 were eligible for the study; their clinical status, underlying morbidities, and AF treatments were assessed. ResultsThe mean age of the study population was 78.6±10.2 years old; more than 90% of the cases were≥65 years old. Permanent AF was the most frequent form of the disease (66.0%), followed by paroxysmal AF (24.1%). Infection was the leading reason for hospitalization (39.2% of cases); AF (or flutter) was the reason for hospitalization in 15.6% of cases. Rate and/or rhythm control therapy was administered in 40.6% of cases at the emergency department and in 75.0% of cases at discharge; amiodarone was the most used drug in all clinical scenarios. At admission, anticoagulation therapy was not being used in 64.1% of cases; at discharge (57.2%). The main reason for non-anticoagulation was HAS-BLED≥3 (60%); in 23.5% of the cases there was no explicit reason for non-anticoagulation. ConclusionThe elderly population with AF presents some distinctive characteristics that the current ESC guidelines do not consistently address. There is a need to develop guidelines tailored to the elderly population, allowing the use of validated, systematic treatment approaches in this highly relevant population.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call